title: Editorial commentary: a Shigella vaccine against prevalent serotypes.
authors: Vaccine Development Global Program, PATH, Washington, District of Columbia.
authors: Lillian L
authors: LL
authors: Van de Verg
authors: Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland.
authors: Malabi M
authors: MM
authors: Venkatesan
mesh_terms: D055808:Drug Discovery / Q000379:methods*; D004405:Dysentery, Bacillary / Q000453:epidemiology* / Q000382:microbiology*; D005260:Female; D006801:Humans; D008297:Male; D012760:Shigella / Q000145:classification* / Q000302:isolation & purification*; D022281:Shigella Vaccines / Q000276:immunology* / Q000302:isolation & purification*
chemical_list: D022281:Shigella Vaccines
keywords: O-antigen; Shigella; cross-reactivity; prevalence; vaccine